AOL Money & Finance

mcmoran posts

Feed

Analyst upgrades: CVH, ERTS, NOK and MRK

MOST NOTEWORTHY: Merck (MRK), McMoRan Exploration (MMR), TheStreet.com (TSCM), Goodrich Petroleum (GDP) and Coventry Health (CVH) were today's noteworthy upgrades:
  • Cowen is optimistic on Merck's (NYSE: MRK) business momentum, key products, and pipeline, and upgraded the pharmaceutical giant to Outperform from Neutral.
  • JP Morgan believes the recent discoveries have created a lower risk profile for McMoRan Exploration (NYSE: MMR), upgrading shares to Overweight from Neutral.
  • Needham upgraded shares of TheStreet.com (NASDAQ: TSCM) to Strong Buy from Buy on the Corsis acquisition as they believe the deal strengthens the company's advertising business.
  • Jefferies upgraded shares of Goodrich Petroleum (NYSE: GDP) to Buy from Underperform as they believe success at the James Lime development program will grow production and cash flow.
  • Banc of America upgraded Coventry Health (NYSE: CVH) to Neutral from Sell as they believe the company's three recent acquisitions will accelerate growth beginning next year...

OTHER UPGRADES:

  • WestLB upgraded Nokia (NYSE: NOK) to Buy from Add.
  • Buckingham upgraded DirecTV (NYSE: DTV) to Neutral from Underperform.
Analyst summaries provided by TheFlyOnTheWall.com (subscription required).

Analyst downgrades 6-15-07: BBW, CAL, FCX, PGR and TAP

MOST NOTEWORTHY: Continental Airlines, Inc (CAL), Molson Coors Brewing Co (TAP), Watsco, Inc (WSO), K-V Pharmaceutical Co (KV.A), Progressive Corp (PGR) and Color Kinetics (CLRK) were today's noteworthy downgrades:
  • Goldman downgraded shares of Continental Airlines, Inc (NYSE: CAL) to Neutral from Buy on valuation, higher oil prices and a weak domestic market.
  • Goldman also downgraded Molson Coors Brewing Co (NYSE: TAP) to Neutral from Buy based on the increase in analyst estimates, valuation and the potential for margin pressure in the summer.
  • BB&T cut Watsco, Inc (NYSE: WSO) to Hold from Buy based on valuation and catalysts that are already reflected in the share price.
  • Roth Capital downgraded shares of K-V Pharmaceutical Co (NYSE: KV.A) to Hold from Buy, telling clients they have learned that Par Pharmaceuticals Cos (PRX) has launched generics of 50, 100 and 200mg Toprol-XL. The firm expects a material impact to KV's 100 and 200mg strength generics.
  • Stifel expects investor enthusiasm regarding Progressive's Corp (NYSE: PGR) recapitalization plan to fade as underwriting fundamentals deteriorate and cut shares to Sell from Hold.
  • Color Kinetics (NASDAQ: CLRK) was downgraded to Hold from Sell at Needham on valuation...
OTHER DOWNGRADES:
Analyst summaries provided by TheFlyOnTheWall.com (subscription required).

Symbol Lookup
IndexesChangePrice
DJIA+44.2910,291.26
NASDAQ+15.822,166.90
S&P 500+5.501,098.51

Last updated: November 11, 2009: 08:38 PM

BloggingStocks Exclusives

Hot Stocks

DailyFinance Headlines

Latest from BloggingBuyouts

WalletPop Headlines

AOL Business News

BioHealth Investor Headlines

Sponsored Links

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance